Strategy Inc (MSTR) director exercises options and sells 1,400 shares
Rhea-AI Filing Summary
Strategy Inc director Jarrod M. Patten exercised stock options for 700 shares of Class A Common Stock on March 31, 2026 and another 700 shares on April 1, 2026 at an exercise price of $18.654 per share.
On the same dates he sold 700 shares at a weighted average price of about $122.007 and 700 shares at $124.640 in open-market transactions. Following these trades, he directly held 28,000 Class A Common shares, along with disclosed holdings of Series A Perpetual preferred stock classes.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Director Stock Option (Right to buy) | 700 | $0.00 | -- |
| Exercise | Class A Common Stock | 700 | $18.654 | $13K |
| Sale | Class A Common Stock | 700 | $122.007 | $85K |
| Exercise | Director Stock Option (Right to buy) | 700 | $0.00 | -- |
| Exercise | Class A Common Stock | 700 | $18.654 | $13K |
| Sale | Class A Common Stock | 700 | $124.64 | $87K |
| holding | Series A Perpetual Strife Preferred Stock | -- | -- | -- |
| holding | Series A Perpetual Stretch Preferred Stock | -- | -- | -- |
| holding | Series A Perpetual Stride Preferred Stock | -- | -- | -- |
Footnotes (1)
- The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.990 to $122.030, inclusive. The reporting person undertakes to provide to Strategy Inc ("Strategy"), any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. The 700 shares exercised on March 31, 2026 pursuant to this option vested on May 31, 2017. Of the remaining 47,900 shares subject to this option, 10,400 shares vested on May 31, 2017, 12,500 shares vested on May 31, 2018, 12,500 shares vested on May 31, 2019, and 12,500 shares vested on May 31, 2020. The 700 shares exercised on April 1, 2026 pursuant to this option vested on May 31, 2017. Of the remaining 47,200 shares subject to this option, 9,700 shares vested on May 31, 2017, 12,500 shares vested on May 31, 2018, 12,500 shares vested on May 31, 2019, and 12,500 shares vested on May 31, 2020.
Key Figures
Key Terms
Director Stock Option (Right to buy) financial
weighted average price financial
Series A Perpetual Strife Preferred Stock financial
Series A Perpetual Stretch Preferred Stock financial
Series A Perpetual Stride Preferred Stock financial
open-market sale financial
FAQ
What did MSTR director Jarrod Patten do in this Form 4 filing?
What prices were reported for the MSTR stock sales?
Were these MSTR transactions option exercises or open-market buys?
Does the MSTR Form 4 mention any special trading arrangements?